Pain management in low-resource settings -- anesthesiologists advocate for increased access

March 20, 2018

March 20, 2018 - Increasing the availability of effective pain management in low- to middle-income countries will be an essential part of ongoing efforts to expand global access to safe surgery and anesthesia, according to a special article in the April issue of Anesthesia & Analgesia.

"Pain is a common, widespread problem with some clearly complex barriers that need to be overcome before more effective treatment options can be delivered to our patients across the world," write Roger Goucke, FFPM, of University of Western Australia, Nedland, and Pongparadee Chaudakshetrin, FFPM, of Mahidol University, Bangkok. Their article appears as part of special section devoted to the theme of "Safe Surgery Globally by 2030."

Addressing the Neglected Problem of Pain in Low-Resource Settings

Drs. Goucke and Chaudakshetrin discuss the high burden of uncontrolled pain in low- to middle-income countries. They note that 80 percent of the world population lacks adequate access to pain management, while also experiencing three-fourths of deaths from cancer and HIV. Attention to expanding the availability of effective pain treatments will be an essential part of an ongoing initiative to expand the availability of appropriate surgical services and safe anesthesia around the world.

That effort, called Global Surgery 2030, defines targets for increasing access to surgery worldwide--including an ambitious goal of reaching at least 80 percent coverage of essential surgical and anesthesia services per country by 2030. "It is essential that the increase in surgical procedures is accompanied by appropriate acute pain management," Drs. Goucke and Chaudakshetrin write.

It has been estimated that one in five adults worldwide suffer from pain, while one in ten are diagnosed with chronic pain each year. Although 80 to 90 percent of cancer pain can be controlled with appropriate use of oral opioids, progress has been "exceptionally slow" in delivering opioids to patients in need. Only 6.7 percent of the world's supply of medical opioids is available to low- and middle-income countries.

The authors note a wide range of barriers to improving access to these and other effective medications for controlling pain. These include distribution difficulties, regulatory requirements, staffing issues, and patients' cultural or religious beliefs. Global health, anesthesia, and pain medicine societies have taken the position that access to appropriate pain relief should be a basic human right.

Drs. Goucke and Chaudakshetrin outline some broad strategies that will be essential to making progress toward universal access to pain treatment. These include a commitment to education in multidisciplinary pain medicine, both in medical and nursing schools and for practicing healthcare workers. Once governments have been made aware of the scope and cost of the problem, the world healthcare community must be prepared to respond with information and guidance--including the need to balance regulation and control of opioids and their use in cancer, postoperative, and trauma pain.

Drs. Goucke and Chaudakshetrin conclude: "With our increasing knowledge of the mechanisms of pain and the complex interaction between the social, psychological, environmental and physical components, we must do more to address these issues not only in the low resource setting but also in high income countries."

Increasing access to treatment for cancer and postoperative pain is only part of anesthesia's responsibility for reaching the Global Surgery 2030 goals, according to an editorial by Robert J. McDougall, MD, of University of Melbourne and Angela Enright, MB, of University of British Columbia. Other topics in the special issue include examples of highly successful training programs to address the shortage of anesthesia providers; considerations to help ensure that the expanded availability of surgery is accompanied by efforts to improve and maintain safety in anesthesia; the development and use of standards to measure progress toward global goals; and the special challenges of expanding obstetric care, including cesarean section.

"Lack of access to safe anesthesia and surgery threatens 5 of the 7 billion people who occupy this planet," Drs. McDougall and Enright write. They add that world governments and the anesthesia community have a "moral imperative" to act in increasing the availability of surgery, anesthesia, and pain treatment. "For those 5 billion people in need, it is their human right to expect that we will."
-end-
Anesthesia & Analgesia is published by Wolters Kluwer.

Read the article in Anesthesia & Analgesia.
-end-
About Anesthesia & AnalgesiaAnesthesia & Analgesia was founded in 1922 and was issued bi-monthly until 1980, when it became a monthly publication. A&A is the leading journal for anesthesia clinicians and researchers and includes more than 500 articles annually in all areas related to anesthesia and analgesia, such as cardiovascular anesthesiology, patient safety, anesthetic pharmacology, and pain management. The journal is published on behalf of the IARS by Lippincott Williams & Wilkins (LWW), a division of Wolters Kluwer Health.

About the IARSThe International Anesthesia Research Society is a nonpolitical, not-for-profit medical society founded in 1922 to advance and support scientific research and education related to anesthesia, and to improve patient care through basic research. The IARS contributes nearly $1 million annually to fund anesthesia research; provides a forum for anesthesiology leaders to share information and ideas; maintains a worldwide membership of more than 15,000 physicians, physician residents, and others with doctoral degrees, as well as health professionals in anesthesia related practice; sponsors the SmartTots initiative in partnership with the FDA; supports the resident education initiative OpenAnesthesia; and publishes two journals, Anesthesia & Analgesia and A&A Case Reports.

About Wolters Kluwer Wolters Kluwer is a global leader in professional information, software solutions, and services for the health, tax & accounting, finance, risk & compliance, and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer, headquartered in the Netherlands, reported 2017 annual revenues of €4.4 billion. The company serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide.

Wolters Kluwer Health is a leading global provider of trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.

Wolters Kluwer Health

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.